MedPath

Sitafloxacin

Generic Name
Sitafloxacin
Drug Type
Small Molecule
Chemical Formula
C38H42Cl2F4N6O9
CAS Number
163253-35-8
Unique Ingredient Identifier
9TD681796G

Overview

No overview information available.

Indication

用于治疗严重的、耐药菌引起的难治性细菌感染性疾病。如咽炎、喉炎、扁桃体炎、急性支气管炎、感染性肺炎、慢性呼吸系统疾病的继发感染;膀胱炎、肾盂肾炎、尿道炎;宫颈炎;中耳炎、鼻窦炎;牙周炎、冠周炎等。

Associated Conditions

  • Bacterial Pneumonia
  • Bacterial Sinusitis
  • Cervicitis
  • Cystitis
  • Otitis Media (OM)
  • Periodontitis
  • Tonsillitis
  • Urethritis

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Sitafloxacin Tablets
国药准字HJ20190022
化学药品
片剂
12/20/2023
Sitafloxacin Tablets
国药准字H20213550
化学药品
片剂
6/25/2021
Sitafloxacin Tablets
国药准字H20249655
化学药品
片剂
12/1/2024
Sitafloxacin Tablets
国药准字H20223425
化学药品
片剂
6/28/2022
Sitafloxacin Tablets
国药准字H20233651
化学药品
片剂
6/7/2023
Sitafloxacin Tablets
国药准字H20213601
化学药品
片剂
7/20/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.